AZN:

p11,560.00

-8.49%

AstraZeneca plc

GBX as of Aug 3, 2026 | LSE - London Stock Exchange

Company Profile FTSE 100 FTSE 350 FTSE All-Share

1-Year Price Evolution & Moving Averages

1-Year: +3.03%

Multi-timeframe price chart with technical indicators - Penny sterling (GBX)

Company Description

Company Profile

AstraZeneca plc researches, develops, manufactures, and commercializes medicines and vaccines across oncology, cardiovascular, respiratory, immunology, rare diseases, and other therapeutic areas.

United Kingdom Healthcare Drug Manufacturers—General UK Healthcare UK Drug Manufacturers—General

Risk & Valuation

as of Aug. 1, 2026

Beta	0.23
Trailing PE	26.16
Forward PE	15.25

Stock Data

Open	p11,720.00
High	p12,082.00
Low	p11,542.00
Close	p11,560.00
Volume	5,154,004
Previous Close	p12,632.00
1-Day Change	-1072.00
1-Year Change	+340.00
Average Daily Volume	2,367,954
52-Week High	p15,542.00
52-Week Low	p10,922.00

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.